Influence of molecular genetics in Vogt-Koyanagi-Harada disease

被引:23
作者
Ng J.Y.W. [1 ]
Luk F.O.J. [1 ]
Lai T.Y.Y. [1 ]
Pang C.-P. [1 ]
机构
[1] Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F Hong Kong Eye Hospital, 147K Argyle Street, Kowloon
基金
英国医学研究理事会;
关键词
Genetics; Human leukocyte antigen; Interleukins; Single-nucleotide polymorphisms; Vogt-Koyanagi-Harada disease;
D O I
10.1186/s12348-014-0020-1
中图分类号
学科分类号
摘要
Vogt-Koyanagi-Harada (VKH) disease is a systemic autoimmune disorder against melanocytes. Recent studies have identified multiple genetic factors that might be associated with the pathogenesis of VKH disease. We performed an electronic database search of PubMed, MEDLINE, and EMBASE, and all relevant papers published up to 13 June 2014 were reviewed. A total of 1,031 publications including articles relevant to the genetics of VKH disease and the references of these articles were reviewed. The review identified a number of genetic factors which might be involved in the pathogenesis of VKH disease, some of which may alter the clinical course of VKH disease. Genes which might be involved in the pathogenesis of VKH disease included genes expressing HLA, complement factor H, interleukins, cytotoxic T-lymphocyte antigen 4 (CTLA-4), killer cell immunoglobulin-like receptors (KIR), programmed cell death 1 (PDCD1), protein tyrosine phosphatase non-receptor 22 (PTPN22), osteopontin, tumor necrosis factor alpha-induced protein 3 (TNFAIP3), macrophage migration inhibitory factor (MIF), and other immune response genes. Further studies to explore the correlation among different genotypes and phenotypes of VKH disease will be useful to shed light on the pathogenesis of uveitis in VKH disease and may facilitate the development of new treatment modalities of uveitis in VKH disease. © 2014, Ng et al.
引用
收藏
页码:1 / 12
页数:11
相关论文
共 140 条
[1]  
Yamaki K., Gocho K., Hayakawa K., Kondo I., Sakuragi S., Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease, J Immunol, 165, pp. 7323-7329, (2000)
[2]  
Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., Pivetti-Pezzi P., Tessler H.H., Usui M., Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature, Am J Ophthalmol, 131, pp. 647-652, (2001)
[3]  
Kitamura M., Takami K., Kitaichi N., Namba K., Kitamei H., Kotake S., Ohno S., Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease, Am J Ophthalmol, 139, pp. 1080-1085, (2005)
[4]  
Tabbara K.F., Chavis P.S., Freeman W.R., Vogt-Koyanagi-Harada syndrome in children compared to adults, Acta Ophthalmol Scand, 76, pp. 723-726, (1998)
[5]  
Wang Y., Chan C.C., Gender differences in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia, J Ophthalmol, 2014, (2014)
[6]  
Yang P., Zhang Z., Zhou H., Li B., Huang X., Gao Y., Zhu L., Ren Y., Klooster J., Kijlstra A., Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China, Curr Eye Res, 30, pp. 943-948, (2005)
[7]  
Moorthy R.S., Inomata H., Rao N.A., Vogt-Koyanagi-Harada syndrome, Surv Ophthalmol, 39, pp. 265-292, (1995)
[8]  
Yamaki K., Hara K., Sakuragi S., Application of revised diagnostic criteria for Vogt-Koyanagi-Harada disease in Japanese patients, Jpn J Ophthalmol, 49, pp. 143-148, (2005)
[9]  
Sasamoto Y., Ohno S., Matsuda H., Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease, Ophthalmologica, 201, pp. 162-167, (1990)
[10]  
Rubsamen P.E., Gass J.D., Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome, Arch Ophthalmol, 109, pp. 682-687, (1991)